Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD (NCT07169123)
🩺 Plain-English Summary (8th-Grade Level)
The study looks at how eating salt affects gut health in people with Crohn's disease. The aim of the study is to find out whether eating more salt increases the breakdown of proteins in the gut and if this makes inflammation and symptoms worse. By studying the link between salt, gut bacteria and inflammation, the study hopes to improve diet advice for people with Crohn's disease. This research may help find specific foods that affect the disease and lead to better, more personalized nutrition plans.
Who can join: Review the eligibility criteria below.
Location: McMaster University — Hamilton, Ontario
Age range: 18 Years to 70 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- McMaster University — Hamilton, Ontario
- McMaster University Medical Centre — Hamilton, Ontario
📞 Contact the Study Coordinator
Phone: (905) 521-2100
Email: ruedag@mcmaster.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Crohns Disease
- Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease — Dothan, Alabama
- Oral N-acetylglucosamine in Crohn's Disease — Baltimore, Maryland
- Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation — New York, New York
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants — Atlanta, Georgia
- Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy — Rochester, Minnesota
Explore by condition: All Crohns Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.